key: cord-0975497-hutbyrh8 authors: Shahali, Hamze; Abadi, Amin Talebi Bezmin; Farahani, Azade Amirabadi; Darvishi, Mohammad title: Mareo al volar irresoluble asociado a la infección por COVID-19: caso clínico date: 2020-11-25 journal: Vacunas DOI: 10.1016/j.vacun.2020.11.001 sha: c776c55b537d1c115435a9bd30083489f9916acd doc_id: 975497 cord_uid: hutbyrh8 A 29-yr-old male Melicopter co-pilot with high flight hours in air transport missions of the patients with COVID-19 tested positive for his RT-PCR due to clinical suspicion. With the diagnosis of COVID-19, he was treated based on the national protocol and stayed in the home quarantine for two weeks. Having been released for flying, he faced nausea, vomiting, facial cold sweat and pallor, dizziness, and imbalance that eventually caused flying avoidance during the three first flights. He has never had a similar problem or any predisposing factors during his pilot’s training and afterwards. All the probable reasons ruled out after a complete assessment. Following the diagnosis of moderate airsickness, he was abstained from flying and treated with different prevention and rehabilitation techniques. None of them had enough clinical efficacies, applying the United States Air Force Preventive Airsickness Protocol as the last choice. Despite the three separate consecutive therapeutic courses, no significant clinical improvement was observed, and could not return to fly, yet. That is the first reported case of intractable airsickness in a flight crew that may be associated with COVID-19 infection. Un varón de 29 años de edad, copiloto de helicóptero médico, con gran número de horas de vuelo en misiones de transporte aéreo de los pacientes de COVID-19, dio positivo en las pruebas rápidas de PCR, debido a sospecha clínica. Diagnosticándose COVID-19, fue tratado sobre la base del protocolo nacional, permaneciendo en cuarentena domiciliaria durante dos semanas. Habiendo sido eximido de volar, padeció náuseas, vómitos, sudores fríos y palidez facial, mareos y falta de equilibrio, que le abstuvieron de volar durante las primeras tres semanas. No había tenido nunca un problema similar ni factores predisponentes durante su formación como piloto, ni después de esta. Tras un reconocimiento completo se descartaron todas las causas probables. Al diagnosticarse mareo moderado al volar, se le recomendó que se abstuviera de viajar en avión, tratándosele con diferentes técnicas de prevención y rehabilitación. Ninguna de ellas tuvo eficacia clínica suficiente, aplicándose el Protocolo para la prevención de mareo al volar de las Fuerzas Aéreas de los Estados Unidos como última elección. A pesar de realizar los tres cursos terapéuticos separados consecutivos no se observó una mejora clínica significativa, y no pudo volver a volar. Se trata del primer caso reportado de mareo al volar irresoluble en una tripulación de vuelo, que puede estar asociado a la infección por COVID-19. J o u r n a l P r e -p r o o f Mareo al volar irresoluble asociado a la infección por COVID-19: caso clínico Un varón de 29 años de edad, copiloto de helicóptero médico, con gran número de horas de vuelo en misiones de transporte aéreo de los pacientes de COVID-19, dio positivo en las pruebas rápidas de PCR, debido a sospecha clínica. Diagnosticándose COVID-19, fue tratado sobre la base del protocolo nacional, permaneciendo en cuarentena domiciliaria durante dos semanas. Habiendo sido eximido de volar, padeció náuseas, vómitos, sudores fríos y palidez facial, mareos y falta de equilibrio, que le abstuvieron de volar durante las primeras tres semanas. No había tenido nunca un problema similar ni factores predisponentes durante su formación como piloto, ni después de esta. Tras un reconocimiento completo se descartaron todas las causas probables. Al diagnosticarse mareo moderado al volar, se le recomendó que se abstuviera de viajar en avión, tratándosele con diferentes técnicas de prevención y rehabilitación. Ninguna de ellas tuvo eficacia clínica suficiente, aplicándose el Protocolo para la prevención de mareo al volar de las Fuerzas Aéreas de los Estados Unidos como última elección. A pesar de realizar los tres cursos terapéuticos separados consecutivos no se observó una mejora clínica significativa, y no pudo volver a volar. Se trata del primer caso reportado de mareo al volar irresoluble en una tripulación de vuelo, que puede estar asociado a la infección por COVID-19. COVID-19, SARS-CoV-2, Mareo al volar irresoluble, Piloto, Transporte aeromédico Introduction SARS-CoV-2 (COVID-19) is a new human pathogen, and world health care systems are currently facing the pandemic of a virus with no specific treatment or vaccination options that mostly affects the respiratory system ranging from mild flu-like symptoms to severe acute respiratory syndrome (SARS), but extra respiratory multi-systemic involvement has also been reported Page 3 of 7 J o u r n a l P r e -p r o o f [1, 2] . Neurological manifestations are not common but reported during the acute phase and treatment period [3] . Being a neurotrophic, neuroinvasive, and neuroinflammatory virus [4] , Li et al. recently described the neuroinvasive potential of COVID-19. A 29-yr-old male Medicopter (Mil, Mi-17) co-pilot with high flight hours in air transport missions of the patients with COVID-19 tested positive for his nasopharyngeal specimen RT-PCR due to clinical suspicion. With the diagnosis of COVID-19, he was treated based on the national protocol and recommended for rest and staying in quarantine for two weeks at home. Three weeks later, in the follow-up session with the aeromedical examiner, he was in good clinical condition except for mild malaise and then released for flying. During the first three flights, he faced several irritating features as nausea, vomiting, facial cold sweat and pallor, dizziness, and imbalance that eventually caused flying avoidance. He has never had a similar problem or any predisposing factors during his pilot's training and afterwards. Before the airsickness diagnosis, during a full and exact clinical and paraclinical (Electronystagmography and Brain MRI) assessment, all the probable reasons which may have been the cause of these features must be ruled out as differential diagnosis (tab.1). J o u r n a l P r e -p r o o f Then, with the diagnosis of moderate airsickness, base on the airsickness severity scoring, he was suspended from flying and treated with a wide range of preventative methods as adaptation, desensitization training, relaxation therapy, behavioral therapy, and medication modalities, but after a month, there was no significant improvement. In the last attempt to recover and return to flying, the United States Air Force (USAF) preventive airsickness protocol was conducted, as the most effective and acceptable combined method (Tab.2). Behavioral Airsickness is a common and complex syndrome that could be an inappropriate response to an abnormal real or perceived motion stimulus. Although the exact neurobiological mechanism is unclear, the widely accepted "Sensory Conflict or Neural Mismatch" hypothesis proposes that the motion stimulus has to be abnormal in such a way as to generate illegitimate combinations of motion sensation either within the components of the vestibular system or between visual and vestibular evidence of motion. This theory has been very successful in explaining the features of those types of motion that provoke sickness, but it does not address the question as to why nausea and vomiting, or for that matter, any symptoms, should be associated with these Airsickness presentation can be diverse, ranging from nausea and vomiting (the most common), facial cold sweating, pallor, headache, drowsiness, dizziness, imbalance, yawning, loss of appetite, and increased salivation that may lead to flying avoidance. So, it is a debilitating condition that harms flight crew performance and is quite unable to perform its allotted duties. There is considerable individual variability in susceptibility and a variety of techniques that are available for assessing an individual's vulnerability [5] [6] [7] [8] [9] . Airsickness is also one of the most common causes of flying avoidance during flight training and eventually may leads to early and permanent medical disqualification, especially in military cadets [10] . These days, behavioral therapy, especially a combination of biofeedback, progressive exposure, and autogenic training, is more common and acceptable. Yet, the USAF preventive airsickness protocol is the most effective and reliable combined method, and 85 percent of the aircrews were taken back to flying. That is a combination therapy that by learning to control the autonomic responses and allay anxiety evoked by motion stimuli, susceptibility to motion sickness will be decreased and the rate at which protective adaptation acquired will be enhanced [9] . SARS-CoV-2 has the potential to produce different extra respiratory multisystemic (particularly neurological) involvement as an immune-mediated process and complexes [3] [4] . In conclusion, this is the first reported case of intractable airsickness associated with COVID-19 infection. Considering the probable pathophysiology of airsickness and the possibility of multisystemic involvement in COVID-19, the authors believe that these features, in this case, maybe due to vestibular, visual, or neural systems involvement. More research and investigations should be done by expert colleagues to clarify the definitive causes in the future. The convalescent sera option for containing COVID-19 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Its Neurologic Manifestations, and Complications The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Motion Sickness: Current Knowledge and Recent Advance Motion sickness Motion sickness: more than nausea and vomiting Motion sickness: advances in pathogenesis, prediction, prevention, and treatment Enesting's Aviation and Space Medicine Determine the medical causes and diseases which led to early and permanent medical disqualification of military cadets